Nick Leschly, bluebird bio CEO (Jeff Rumans)
Bobbing on a sea of crises, bluebird's Nick Leschly sees his pay cut in half as the biotech prepares to split
It wasn’t so long ago that bluebird bio and CEO Nick Leschly were the darling of biotech, using a lentiviral vector approach that looked to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
